120 related articles for article (PubMed ID: 25369781)
1. DNA repair in diffuse large B-cell lymphoma: a molecular portrait.
Bret C; Klein B; Cartron G; Schved JF; Constantinou A; Pasero P; Moreaux J
Br J Haematol; 2015 Apr; 169(2):296-9. PubMed ID: 25369781
[No Abstract] [Full Text] [Related]
2. Role of molecular subtype in predicting outcome of AIDS-related diffuse large B-cell lymphoma.
Dunleavy K; Wilson WH
J Clin Oncol; 2010 Jun; 28(16):e260; author reply e261-2. PubMed ID: 20421532
[No Abstract] [Full Text] [Related]
3. Molecular outcome prediction in diffuse large-B-cell lymphoma.
Alizadeh AA; Gentles AJ; Lossos IS; Levy R
N Engl J Med; 2009 Jun; 360(26):2794-5. PubMed ID: 19553658
[No Abstract] [Full Text] [Related]
4. New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma.
Frick M; Dörken B; Lenz G
Best Pract Res Clin Haematol; 2012 Mar; 25(1):3-12. PubMed ID: 22409819
[TBL] [Abstract][Full Text] [Related]
5. Diffuse large B cell lymphoma: how can we cure more patients in 2012?
Moskowitz C
Best Pract Res Clin Haematol; 2012 Mar; 25(1):41-7. PubMed ID: 22409822
[TBL] [Abstract][Full Text] [Related]
6. State-of-the-art therapeutics: diffuse large B-cell lymphoma.
Coiffier B
J Clin Oncol; 2005 Sep; 23(26):6387-93. PubMed ID: 16155024
[TBL] [Abstract][Full Text] [Related]
7. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
Jardin F; Ruminy P; Kerckaert JP; Parmentier F; Picquenot JM; Quief S; Villenet C; Buchonnet G; Tosi M; Frebourg T; Bastard C; Tilly H
Haematologica; 2008 Apr; 93(4):543-50. PubMed ID: 18287131
[TBL] [Abstract][Full Text] [Related]
8. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes.
Lossos IS; Czerwinski DK; Alizadeh AA; Wechser MA; Tibshirani R; Botstein D; Levy R
N Engl J Med; 2004 Apr; 350(18):1828-37. PubMed ID: 15115829
[TBL] [Abstract][Full Text] [Related]
9. DNA repair gene XRCC1 polymorphisms and haplotypes in diffuse large B-cell lymphoma in a Korean population.
Kim IS; Kim DC; Kim HG; Eom HS; Kong SY; Shin HJ; Hwang SH; Lee EY; Kim S; Lee GW
Cancer Genet Cytogenet; 2010 Jan; 196(1):31-7. PubMed ID: 19963133
[TBL] [Abstract][Full Text] [Related]
10. Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma.
Vitolo U; Botto B; Capello D; Vivenza D; Zagonel V; Gloghini A; Novero D; Parvis G; Calvi R; Ariatti C; Milan I; Bertini M; Boccomini C; Freilone R; Pregno P; Orsucci L; Palestro G; Saglio G; Carbone A; Gallo E; Gaidano G
Leukemia; 2002 Feb; 16(2):268-75. PubMed ID: 11840294
[TBL] [Abstract][Full Text] [Related]
11. Therapy of diffuse large B-cell lymphomas.
Pfreundschuh M
Eur J Cancer; 2009 Sep; 45 Suppl 1():386-7. PubMed ID: 19775641
[No Abstract] [Full Text] [Related]
12. Rituximab with chemotherapy improves survival of non-germinal center type untreated diffuse large B-cell lymphoma.
Saito B; Shiozawa E; Usui T; Nakashima H; Maeda T; Hattori N; Shimozuma J; Adachi D; Yamochi-Onizuka T; Takimoto M; Nakamaki T; Ota H; Tomoyasu S
Leukemia; 2007 Dec; 21(12):2563-6. PubMed ID: 17597802
[No Abstract] [Full Text] [Related]
13. Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma?
Ferreri AJ; Dognini GP; Govi S; Crocchiolo R; Bouzani M; Bollinger CR; D'Incan M; Delaporte E; Hamadani M; Jardin F; Martusewicz-Boros M; Montanari M; Szomor A; Zucca E; Cavalli F; Ponzoni M
J Clin Oncol; 2008 Nov; 26(31):5134-6; author reply 5136-7. PubMed ID: 18838697
[No Abstract] [Full Text] [Related]
14. Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
Lin P; Dickason TJ; Fayad LE; Lennon PA; Hu P; Garcia M; Routbort MJ; Miranda R; Wang X; Qiao W; Medeiros LJ
Cancer; 2012 Mar; 118(6):1566-73. PubMed ID: 21882178
[TBL] [Abstract][Full Text] [Related]
15. Dose intensity in the treatment of diffuse large-cell lymphoma.
Anderson JR; Santarelli MT; Peterson B
J Clin Oncol; 1990 Nov; 8(11):1927-8. PubMed ID: 2230883
[No Abstract] [Full Text] [Related]
16. Double-hit diffuse large B-cell lymphoma.
Friedberg JW
J Clin Oncol; 2012 Oct; 30(28):3439-43. PubMed ID: 22949152
[No Abstract] [Full Text] [Related]
17. Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen.
Nakamura N; Goto N; Tsurumi H; Takemura M; Kanemura N; Kasahara S; Hara T; Yasuda I; Shimizu M; Sawada M; Yamada T; Seishima M; Takami T; Moriwaki H
Eur J Haematol; 2013 Oct; 91(4):322-31. PubMed ID: 23672298
[TBL] [Abstract][Full Text] [Related]
18. Diffuse large B-cell lymphoma.
Habermann TM
Clin Adv Hematol Oncol; 2005 Nov; 3(11):suppl 4-5. PubMed ID: 16491628
[No Abstract] [Full Text] [Related]
19. CHOP chemotherapy as standard therapy for treatment of patients with diffuse histiocytic lymphoma.
Fisher RI
Important Adv Oncol; 1990; ():217-25. PubMed ID: 2182520
[No Abstract] [Full Text] [Related]
20. Aberrant expression of CCR4 in diffuse large B-cell lymphoma, not otherwise specified.
Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Hiraoka N; Takayama A; Nishiwaki U; Masuda Y; Nishimura Y; Tsuji M; Hanafusa T
Leukemia; 2013 Dec; 27(12):2382-5. PubMed ID: 23612017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
